These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37059512)

  • 1. Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review.
    Kishino Y; Tohyama S; Morita Y; Soma Y; Tani H; Okada M; Kanazawa H; Fukuda K
    J Card Fail; 2023 Apr; 29(4):503-513. PubMed ID: 37059512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the realization of cardiac regenerative medicine using pluripotent stem cells.
    Kishino Y; Fujita J; Tohyama S; Okada M; Tanosaki S; Someya S; Fukuda K
    Inflamm Regen; 2020; 40():1. PubMed ID: 31938077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
    J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.
    Morita Y; Kishino Y; Fukuda K; Tohyama S
    Cell Prolif; 2022 Aug; 55(8):e13248. PubMed ID: 35534945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells.
    Soma Y; Morita Y; Kishino Y; Kanazawa H; Fukuda K; Tohyama S
    Front Cardiovasc Med; 2021; 8():774389. PubMed ID: 34957258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Cardiac Regenerative Medicine Using Human iPS Cell-derived Cardiomyocytes.
    Fujita J
    Keio J Med; 2021 Sep; 70(3):53-59. PubMed ID: 32830153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism-based cardiomyocytes production for regenerative therapy.
    Umei TC; Tohyama S; Fukuda K
    J Mol Cell Cardiol; 2023 Mar; 176():11-20. PubMed ID: 36681267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
    Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
    Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy.
    Silver SE; Barrs RW; Mei Y
    Front Cardiovasc Med; 2021; 8():707890. PubMed ID: 34820426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise Review: Genetic and Epigenetic Regulation of Cardiac Differentiation from Human Pluripotent Stem Cells.
    Fujita J; Tohyama S; Kishino Y; Okada M; Morita Y
    Stem Cells; 2019 Aug; 37(8):992-1002. PubMed ID: 31021504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
    Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
    Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.
    Floy ME; Mateyka TD; Foreman KL; Palecek SP
    Stem Cell Res; 2020 May; 45():101831. PubMed ID: 32446219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
    Duelen R; Sampaolesi M
    EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marching towards regenerative cardiac therapy with human pluripotent stem cells.
    Maher KO; Xu C
    Discov Med; 2013 Jun; 15(85):349-56. PubMed ID: 23819949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.